Insider Cluster (3 insiders) ·Filed Mar 23, 2026

IMNM

Immunome Inc.
MIXED
Impact 5/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight ◆ Mixed

The CEO's open-market purchase is a positive signal, but it's offset by a director selling a slightly larger dollar amount. The overall activity is modest and not materially dilutive or accretive. Traders should monitor for follow-up transactions, especially additional buying from the CEO.

DirectionMixed
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IMNM ▼ -10.70% at T+60d
NEUTRAL call ✗ call lost -10.70% · α vs SPY -23.76% · entry $20.75 → $18.53
Entry anchored
Mar 20, 03:59 PM ET
via exchange tick
T+1d
-2.60%
call -2.60% · α -2.25%
$20.21
settled 6mo ago
T+5d
-6.99%
call -6.99% · α -3.42%
$19.30
settled 6mo ago
T+20d
+14.94%
call +14.94% · α +7.52%
$23.85
settled 6mo ago
T+60d
-10.70%
call -10.70% · α -23.76%
$18.53
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Immunome Inc. saw mixed insider activity with CEO Clay Siegall purchasing $501K of stock while Director Philip Wagenheim sold $582K. The trades are modest in size relative to the company's $2.5B market cap, with the CEO's buying signaling confidence despite a director's exit.

Key Financial Metrics

Direction
mixed
Total Value
$1.1M
Insiders
3

Key Facts

  • CEO Clay Siegall purchased 25,450 shares in the open market for $500,601.50 at $19.67 per share on March 27, 2026.
  • Director Philip Wagenheim sold 28,200 shares for $582,330 at $20.65 per share on March 23, 2026.
  • CSO Jack Higgins gifted 6,291 shares (non-cash transaction) on March 30, 2026.
  • Total cluster value: $1.08M, representing 0.04% of the company's $2.5B market cap.

Financial Impact

$1.08M in net insider transactions over 7 days, with $501K in buying and $582K in selling. Non-cash gift of 6,291 shares adds no economic value.

insider sentimentshare ownership

Risk Factors

  • Director selling could indicate lack of confidence or portfolio rebalancing.
  • Low volume of insider trades limits the strength of the signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMNM-1775079580899
13 reports for IMNM
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +26.53%May 28, 2026
Filters
Rows
Reports for IMNM — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$21.58 awaiting T+5awaiting T+5—$21.03 (−2.53%)
Sep 21, 2026
11d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$25.07 $21.68▼ −13.52%▼ −13.24%$21.03 (−16.09%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$26.42 $28.08▲ +6.28%▲ +8.25%$21.03 (−20.38%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.25 $27.56▲ +4.99%▲ +5.39%$21.03 (−19.87%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.35 $22.20▼ −4.93%▼ −4.36%$21.03 (−9.91%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.01 $22.59▼ −5.91%▼ −6.78%$21.03 (−12.39%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.01 $22.59▼ −5.91%▼ −6.78%$21.03 (−12.39%)
Jul 3, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$23.61 $24.17▼ −2.37%▼ −1.44%$21.03 (+10.91%)
May 28, 2026
18w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$22.54 $19.81▼ −12.11%▼ −12.06%$21.03 (−6.68%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$22.20 $19.66▼ −11.44%▼ −10.28%$21.03 (−5.25%)
Showing 10 of 13

US Market Status

Market Open — Closes in 1h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 1, 2026